studies toward synthesis of mono-glycosylated ...1049118/fulltext01.pdf · studies toward synthesis...

44
Studies toward synthesis of mono-glycosylated dipyrromethanes and analogues of the anti- cancer natural product tolyporphin Licentiate monograph in Organic Chemistry By Derar Al-Smadi Chemistry Department-BMC Uppsala University

Upload: phungkien

Post on 31-Jan-2018

238 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Studies toward synthesis of mono-glycosylated ...1049118/FULLTEXT01.pdf · Studies toward synthesis of mono-glycosylated dipyrromethanes and analogues of the anti-cancer natural product

Studies toward synthesis of mono-glycosylated

dipyrromethanes and analogues of the anti-

cancer natural product tolyporphin

Licentiate monograph

in

Organic Chemistry

By Derar Al-Smadi

Chemistry Department-BMC

Uppsala University

Page 2: Studies toward synthesis of mono-glycosylated ...1049118/FULLTEXT01.pdf · Studies toward synthesis of mono-glycosylated dipyrromethanes and analogues of the anti-cancer natural product

Abstract

Al-Smadi, D. 2016. Studies toward synthesis of mono-glycosylated dipyrro-methanes and analogues of the anti-cancer natural product tolyporphin.

The tolyporphin A structure contains a tetrapyrrolic bacteriochlorin macrocy-

cle and also consists of two glycosyl groups directly connected to the pyrroles.

In this thesis, 3-glycosylated pyrrole was reacted with Eschenmoser's salt to produce N,N-dimethylamino methylated derivative in 95 % yield. Then, the

product was reacted with pyrrole under microwave irradiation to produce gly-

cosylated dipyrromethane in 44 % yield. Mono-glycosylated porphyrin was

formed by reacting glycosylated dipyrromethane with 1,9-bis (imino)-5-phe-nyl dipyrromethane under the standard procedure, 1H NMR was used to con-

firm the new products.

Keywords: tolyporphins, Eschenmoser salt, pyrrole, 3-glycosylated pyrrole,

glycosylated dipyrromethane, microwave reaction, mono-glycosylated por-phyrin.

Derar Al-Smadi, Uppsala University, Department of Chemistry – BMC, Box 576, SE-751 23 Uppsala, Sweden.

© Derar Al-Smadi, 2016

Page 3: Studies toward synthesis of mono-glycosylated ...1049118/FULLTEXT01.pdf · Studies toward synthesis of mono-glycosylated dipyrromethanes and analogues of the anti-cancer natural product

To my wife, my daughter, and my parents.

Page 4: Studies toward synthesis of mono-glycosylated ...1049118/FULLTEXT01.pdf · Studies toward synthesis of mono-glycosylated dipyrromethanes and analogues of the anti-cancer natural product

Contents

1.Introduction ........................................................................................ 9

1.1 Porphyrins…………………………………………………..9

1.2 Chlorins..…………………………………………………..11

1.3 Bacteriochlorins…………………….……………………..12

1.4 Tolyporphins………………………………………………..13

1.5 Glycosylation Reactions………….………………………..14

1.6 The anomeric selectivity…………………………………..14

1.7 Pyrroles…………………………………………………….14

1.8 Glycosylation of Pyrroles………………………………….16

2. Aim of the project………………………………………18

3. Methods…………………………………………………………19

3.1 Existing methods for bacteriochlorins and tolyporphins….19

3.2 Other methods for producing porphyrins and chlorins deriva-

tives………………………………………………………………...21

3.3 Glycosylated porphyrins chlorins and bacteriochlorins.......22

3.4 Synthesis of tolyporphin A derivatives……………………23

3.5 Glycosylated pyrroles……………………………………..24

3.6 Glycosylation of pyrrole at position 3…………………….24

3.7 Conversion of glycosylated pyrrole to dipyrromethane…..26

3.8 Diglycosylated dipyrromethanes………………………….26

3.9 Preparing porphyrin……………………………………….27

3.10 Mono glycosylation of dipyrromethane in regioselective re-

action………………………………………………………………...27

4. Results and discussion……………………………………….29

4.1 Selectivity of glycosylation of N-TIPS-pyrrole…………..29

4.2 Glycosylation of N-TIPS-pyrrole…………………………29

4.3 Mono-glycosylated dipyrromethane………………………30

4.4 The new results……………………………………………32

Page 5: Studies toward synthesis of mono-glycosylated ...1049118/FULLTEXT01.pdf · Studies toward synthesis of mono-glycosylated dipyrromethanes and analogues of the anti-cancer natural product

4.5 Eschenmoser salt…………………………………………33

4.6 Mono-glycosylated dipyrromethanes…………………….34

4.7 Second of dipyrromethane preparation…………………..35

4.8 preparation of mono-glycosylated porphyrin.....................35

5 Conclusion……………………………………………..37

Page 6: Studies toward synthesis of mono-glycosylated ...1049118/FULLTEXT01.pdf · Studies toward synthesis of mono-glycosylated dipyrromethanes and analogues of the anti-cancer natural product

Figures

1- Structure of porphyrin, heme and TPP…………………………...…9

2- Routes to trans-substituted porphyrins………………………...…..10

3- Structure of chlorin…………………………………………...……11

4- Structure of chlorophyll a and b…………………………...………11

5- Structures of bacteriochlorin, isobacteriochlorin, bacteriochlorophyll

a……………………………………………………………………12

6- Building blocks for tolyporphin A………………………………...13

7- General glycosylation reaction…………………………………….14

8- Anomeric selectivity mechanism………………………………….14

9- Resonance of pyrrole………………………………………………15

10- Examples of natural products containing pyrroles………………...15

11- Drugs containing pyrrole substructures……………………………16

12- Glycosylation of pyrrole using the TCAI method…………………17

13- Glycosylation including acetobromoglucose and InCl3…………...17

14- The product form from the same reaction conditions as given in Fig-

ure 12………………………………………………………………17

15- Overview of reaction steps of the project………………………….18

16- Reduction of TPC to TPBC………………………………………..19

17- Reduction of porphyrin to bacteriochlorin………………………...19

18- Rearrangement of pinacol-pinacolone……………………………..20

19- The number of products from hydroxylation non-symmetrical por-

phyrins……………………………………………………………..21

20- Synthesis of CGlc4, IGlc4 and BGlc4………………………………22

21- Synthesis of PGlc4 from TPPF20…………………………………...23

22- Tolyporphin A with building blocks………………………………23

23- Preparation of pyrrole-C-glycosylated using the glycosyl donors un-

der BF3.Et2O……………………………………………………….24

24- Reaction of the glycosyl donor with TIPS-pyrrole………………..25

25- Preparation of glycosyl donor with new substrate………………...25

26- Preparation of 3-glycosylated pyrrole……………………………..25

27- Pathways of preparation of glycosylated dipyrromethanes……….26

28- Preparation of diglycosylated dipyrromethane……………………26

29- Preparation of Eastern half of dipyrromethane……………………27

30- Preparation of monoglycosylated porphyrin………………………27

Page 7: Studies toward synthesis of mono-glycosylated ...1049118/FULLTEXT01.pdf · Studies toward synthesis of mono-glycosylated dipyrromethanes and analogues of the anti-cancer natural product

31- Reaction of glycosylated pyrrole with Eschenmoser salt……….....28

32- Glycosylated dipyrromethane formation…………………………..28

33- Glycosylated porphyrin formation………………………………...29

34- Preparation of glycosyl donor……………………………………..30

35- Failed strategies to produce glycosylated dipyrromethanes……….31

36- Vilsmeier reaction with glycosylated pyrrole……………………...31

37- Other products from Vilsmeier reaction…………………………...31

38- Bromination of 3- glycosylated pyrrole…………………………...32

39- Bromination of 3- glycosylated pyrrole with other condition……..32

40- Iodination of glycosylated pyrrole…………………………………32

41- Preparation of diglycosylated dipyrromethane…………………….32

42- Preparation of 2-bezoyl-4-glycosylated pyrrole…………………...33

43- Preparation of glycosylpyrrole donor in presence of Eschonmoser

salt………………………………………………………………….33

44- Formation of glycosylated dipyrromethane………………………..34

45- Formylation of dipyrromethane……………………………………35

46- Reaction of the two parts of dipyrromethane……………………...35

Tables

1- Unsuccessful reactions……………………………………………33

2- Optimization reaction of glycosylated dipyrromethane…………...34

Appendix………………………………………………….38

Page 8: Studies toward synthesis of mono-glycosylated ...1049118/FULLTEXT01.pdf · Studies toward synthesis of mono-glycosylated dipyrromethanes and analogues of the anti-cancer natural product

Abbreviations

1- Ac: Acetate.

2- BGlc4: Thioglycosylated bacteriochlorin.

3- Bn: Benzyl.

4- CGlc4: Thioglycosylated chlorin.

5- DBU: 1,6-diaza-bicyclo[5,4,0]undec-6-ene.

6- DCM: Dichloromethane.

7- DDQ: 2,3-dichloro 5,6-dicyano 1,4-benzoquinone.

8- DEA: Di-ethylamine

9- DIPEA: Diisopropylethylamine.

10- Gal: Galactose.

11- Glc: Glucose.

12- HIV: Human immunodeficiency virus.

13- IGlc4: Thioglycosylated isobacteriochlorin.

14- Lac: Lactose.

15- LG: Leaving group.

16- Man: Mannose.

17- MDR: Multidrug resistance.

18- MDRR: Multidrug resistance reversing

19- MesMgBr: Mesitylmagnesium bromide.

20- NBS: N-bromosucinimide.

21- NIS: N-Iodosucinimide.

22- PDT: Photodynamic therapy.

23- rt: Room temperature.

24- PDT: photodynamic therapy.

25- PTFAI: N-phenyl triflouromethylacetimidiate

26- TBAF: tetrabutylammoniumfluoride

27- TCAI: trichloroacetimidate.

28- TFA: Triflouroacetyl.

29- THF: Tetrahydrofuran.

30- TIPS: Triisopropylsilyl.

31- TPP: Tetrphenylporphyrin.

32- TPPF: Tetra(pentaflouro)phenylporphyrin.

.

Page 9: Studies toward synthesis of mono-glycosylated ...1049118/FULLTEXT01.pdf · Studies toward synthesis of mono-glycosylated dipyrromethanes and analogues of the anti-cancer natural product

9

1- Introduction

Tetrapyrrole macrocycle compounds.

Tetrapyrrolic macrocycles such as chlorins and porphyrins are heterocyclic

aromatics containing 18-π aromaticity of the ring system that is responsible

for the high stability of these compounds. In addition, the presence of four

isoindole or pyrrole nitrogen atoms allows tetrapyrrolic macromolecules to

coordinate with several metal ions. Chlorin and bacteriochlorin are partially

hydrated, 2,3-dihydroporphyrins and 7,8,17,18-tetra-hydroporphyrin. These

macrocycles are strongly coloured and fluorescent, but chlorins show stronger

absorption at lower wavelengths compared to the analogous porphyrins.

1.1- Porphyrins.

The porphyrin ring contains a 22-π electron system of fully unsaturated carbon

atoms. It is a biologically active unit found in some natural species like heme

that works as the oxygen-carrying cofactor of hemoglobin and in cytochrome

P450 enzymes enabling catalysis of oxidation processes.

Figure 1. Structure of porphyrin, heme and TPP

Page 10: Studies toward synthesis of mono-glycosylated ...1049118/FULLTEXT01.pdf · Studies toward synthesis of mono-glycosylated dipyrromethanes and analogues of the anti-cancer natural product

10

The porphyrin ring system is built up of four pyrrole rings that are joined

by –CH groups to form the macrocycle. Metalated porphyrins are formed by

replacing the pyrrole hydrogens in the pyrrole core. The diversity of porphyrin

functions in nature and biological systems is caused by the variety of metals

that can bind to the pyrrole core. Because of this, and because of their charac-

teristic electronic and photo-physical properties, the metal derivatives have

gained great attention for their roles in biological systems.

The photosensitizing properties of porphyrin derivatives has led to studies

of their use as sensitizers in certain medical applications such as photody-

namic therapy (PDT) [1]. Also, in recent years, the advantages of the high sta-

bility of porphyrins has opened new avenues of applications in molecular

electronics, information storage [2], solar cells [3], and opto-electronics [4].

1.1.1 Existing Methods of preparation porphyrins.

The most commonly used synthesis of porphyrins was presented by Poul

Rothemund. It uses an condensation and oxidation of pyrrole in the presence

of aldehyde in acidic medium [5]. After that, Alder and Longo refined the syn-

thesis and also other groups around the world found various ways to make

porphyrins and porphyrin analogues [6]. Figure 2 shows the synthetic routes of

trans-substituted porphyrins with two different substituents [7].

Figure 2. Routes to trans-substituted porphyrins.

Page 11: Studies toward synthesis of mono-glycosylated ...1049118/FULLTEXT01.pdf · Studies toward synthesis of mono-glycosylated dipyrromethanes and analogues of the anti-cancer natural product

11

1.2 Chlorins.

Chlorins are important cofactors in Nature. In plants, chlorophyll a and b and

other analogues are providing the basis of one of the most important vital pro-

cesses for life [8] , the photosynthesis. Chlorins also play a role as a medium in

the redox processes catalyzed by some enzymes [9].

Figure 3. Structure of chlorin.

Chlorins are also called hydroporphyrins as they have one pyrrole ring sat-

urated at the β-position. Although porphyrins and chlorins have many similar-

ities, changing the symmetry and conjugation pattern as a result of reduction

of one pyrrole ring gives rise to important differences in their photochemical

properties and applications.

Figure 4. Chlorophyll a and b

Because of the instability of chlorophyll a and b, several modifing studies

have been performed aiming to stabilize there naturally occurring chloro-

phylls. Relatively few functionalities available for modification, however,

made the researchers focus on the synthesis of stable chlorin [10].

Page 12: Studies toward synthesis of mono-glycosylated ...1049118/FULLTEXT01.pdf · Studies toward synthesis of mono-glycosylated dipyrromethanes and analogues of the anti-cancer natural product

12

Selective methods for the total synthesis of some chlorin model system

were developed by Montforts, Battersby and their co-workers [11] . Later on,

the synthesis of naturally occurring chlorin and other dialkylated chlorins was

investigated from the information gathered in these studies.

1.3 Bacteriochlorins.

Bacteriochlorins are tetrapyrrolic macromolecules in which two pyrrole rings

are saturated at the β-position. There are two types of bacteriochlorins, one

with the saturated carbons at opposite sites and the other with the saturated

carbons at neighboring sites, called isobacteriochlorin.

Bacteriochlorins are derived from bacteriochlorophylls prevent in photosyn-

thetic bacteria (Figure 5).

Figure 5. Structures of bacteriochlorin, isobacteriochlorin and bacteriochlorophyll a.

There are some differences between bacteriochlorophyll derivatives. For

instance, bacteriochlorophyll g differ from bacteriochlorophyll b by contain-

ing a vinyl group at the 3-position [12], while bacteriochlorophyll b contains an

acetyl group at the same position. In addition, bacteriochlorophyll b is similar

Page 13: Studies toward synthesis of mono-glycosylated ...1049118/FULLTEXT01.pdf · Studies toward synthesis of mono-glycosylated dipyrromethanes and analogues of the anti-cancer natural product

13

to bacteriochlorophyll a, but contains an exocyclic ethylidene group at the 8-

position. While studying the stability of bacteriochlorophylls, bacteriochloro-

phyll b and g were found to be particularly unstable and are still under re-

search.

1.4 Tolyporphins.

The emergence of broad-spectrum multi-drug resistance (MDR) is a major

problem in cancer chemotherapies [13]. Therefore, compounds that are able to

reverse MDR have high potential to improve the prognosis of the disease.

Moore and co-workers isolated tolyporphin A from the lipophilic extract

of the cyanophyte microalgae Tolypothrix nodosa. After that, tolyporphins (B-

K) have been isolated. Tolyporphin analogues are investigated as MDR-re-

versing agents with the development of new routes to functionalize heterocy-

cles.

Figure 6. Building blocks for tolyporphin A.

Tolyporphins make up a series of bacteriochlorin natural products that dis-

play varying levels of MDR-reversing activity (MDRR) [14]. The total synthe-

sis of tolyporphin A was carried out on a 0.38 mg scale and in ~ 25 steps

(longest linear sequence) [15]. A set of key precursors are shown in Figure 6.

These precursors are expected to be available via modifications of existing

procedures [16]. A variety of substituents can be introduced, enabling the iden-

tification of the substitution pattern necessary for biological activity. How-

ever, a problem associated with tolyporphin is its phototoxicity [14].

Page 14: Studies toward synthesis of mono-glycosylated ...1049118/FULLTEXT01.pdf · Studies toward synthesis of mono-glycosylated dipyrromethanes and analogues of the anti-cancer natural product

14

1.5 Glycosylation reactions.

Glycosylation reactions attach a carbohydrate from a glycosyl donor to func-

tional groups like hydroxyl in an acceptor molecule (Figure 7). In biology,

glycosylation refers specially to the enzymatic process which attaches glycans

to lipids, proteins, or other organic compounds. Glycans serve a variety of

structural and functional roles in membrane and excreted proteins.

Figure 7. General glycosylation reaction [17]

1.6 The anomeric selectivity

The neighbouring carbon atom adjacent to the anomeric carbon can become

involved in the reaction, a situation known as "neighbouring group participa-

tion". This is related to that the interaction of the β-anomer is highly favoured

rendering it more reactive than other atoms. The Figure below shows the

mechanism.

Figure 8. Anomeric selectivity mechanism.

1.7 Pyrroles.

Pyrrole is an aromatic five-membered heterocyclic compound. Pyrrole reac-

tions are controlled by electrophilic aromatic substitution, where the pyrrole

reacts as a nucleophile due to its electron rich structure. The stability of the

pyrrole molecule comes from the high number of resonance structures, (Figure

9).

Page 15: Studies toward synthesis of mono-glycosylated ...1049118/FULLTEXT01.pdf · Studies toward synthesis of mono-glycosylated dipyrromethanes and analogues of the anti-cancer natural product

15

Figure 9. Resonance of pyrrole [18].

Pyrrole is one of the more important heterocycles, and is found in a wide

range of natural products and drug compounds. There are several examples of

natural product molecules containing pyrrole ring. In (Figure 10), compounds

1 and 2 are antibacterial and both isolated from bacterial sources. Nakamunic

acid (compound 3) which has a dimeric structure, is isolated from marine

sources [19].

Figure 10. Examples of natural products containing pyrroles

Furthermore, the pyrrole substructure is also present in a large number of

bioactive compounds like HIV fusion inhibitors [20]. (Figure 11) shows exam-

ples of some drugs containing pyrrole substructures.

Page 16: Studies toward synthesis of mono-glycosylated ...1049118/FULLTEXT01.pdf · Studies toward synthesis of mono-glycosylated dipyrromethanes and analogues of the anti-cancer natural product

16

Figure 11. Drugs containing pyrrole substructures.

1.8 Glycosylation of pyrrole.

The leaving group connected to the anomeric carbon atom of a glycone (gly-

cosyl donor) in glycosylation reactions can be substituted by a nucleophilic

acceptor in the presence of a promoter like a Lewis acid (Figure 7). During

the reaction, an oxonium ion is formed as an intermediate due to the activation

of the glycosyl donor, this oxonium ion is usually considered as the active

species and the key intermediate in a glycosylation reaction. Stereoselectivity,

yield, and by-products are determined by the mixture of oxonium-ion and its

protecting groups, the promoter, the solvent, the leaving group, and the nucle-

ophile [17]. Armitt and co-workers reported direct formation of a C-glycosidic

bond to pyrrole. They reported the selective glycosylation of pyrrole using

trichloroacetimidate (TCAI) donors and BF3·Et2O as the promoter. (Figure

12) shows the glycosylation of pyrrole and N-TIPS-pyrrole with the maltosyl

pyrrole TCAI donor to give the 2-substiuted glycosyl pyrrole and the 3-sub-

stituted glycosyl pyrrole.

Page 17: Studies toward synthesis of mono-glycosylated ...1049118/FULLTEXT01.pdf · Studies toward synthesis of mono-glycosylated dipyrromethanes and analogues of the anti-cancer natural product

17

Figure 12. Glycosylation of pyrrole using the TCAI method, (a) pyrrole (5.0 eq), BF3.Et2O (2.5 eq), DCM. 4Å powdered molecular sieves, -50 °C, 20 min, 84% yield (b), same conditions as in a, but with N-TIPS-pyrrole, 31% yield (1:1.25 mix of α- and β- anomers) .

In 2005 another method for selective C-glycosylation of pyrrole was pub-

lished. 2,3,4,6-tetra-acetylbromoglucose was used with InCl3 as a promoter [21]. The product was a mixture of 2-, and 3-substituted pyrroles in 3:1 ratio

respectively.

Figure 13. Glycosylation using acetobromoglucose and InCl3, the reaction condi-

tions were, pyrrole, InCl3, DCM, at 0 °C, 84% yield.

The same method was used in a reaction with indole to form the glycosyl-

ated indole (Figure 14).

Figure 14. The product form from the same reaction conditions as given in Figure 12.

Page 18: Studies toward synthesis of mono-glycosylated ...1049118/FULLTEXT01.pdf · Studies toward synthesis of mono-glycosylated dipyrromethanes and analogues of the anti-cancer natural product

18

2 Aim of the project

Many researches have worked on the chemistry of porphyrins and chlorins,

and a wide range of methods have been applied, in which pyrroles and dipyr-

romethane fulfill key roles in the synthesis. One of our goals is the synthesis

of multi-drug resistance-reversing natural products and synthetic analogues

thereof. A second objective is to apply new strategies for the production of

functionalized hetero-cycle compounds using glycosylated donors, and the de-

velopment of new synthesis routes resulting in selectivity and better yields

(Figure 15). Comparisons between this work and other strategies regarding

selectivity and the yields is described.

Figure 15. Overview of reaction steps of the project.

Page 19: Studies toward synthesis of mono-glycosylated ...1049118/FULLTEXT01.pdf · Studies toward synthesis of mono-glycosylated dipyrromethanes and analogues of the anti-cancer natural product

19

3 Methodology

Bacteriochlorins can be prepared by known methods, and here follows a sum-

mary of methods that can be used to prepare and modify bacteriochlorin and

tolyporphin derivatives for use as synthetic building blocks. The advantages

as well as disadvantages of these methods are also discussed.

3.1 Existing methods for bacteriochlorins and tolyporphins.

In 1952 Dorough and Miller reduced meso-tetraphenylchlorin (TPC) to meso-

tetraphenylbacteriochlorin (TPBC) by using catalytic hydrogenation shown in

(Figure 16) [22], the absorption spectrum of the product was similar to bacteri-

ochlorophyll a. On the other hand, total synthesis process can be used to pro-

duce other series of bacteriochlorin such as tolyporphins (Figure 6).

Figure 16. Reduction of TPC to TPBC

Later on, more efficient methods were presented, which studied the selec-

tivity of preparation of bacteriochlorin from porphyrin [22-23].

Figure 17. Reduction of porphyrin to bacteriochlorin.

Note that most bacteriochlorins prepared by reductive hydrogenation are

not stable, because of their high sensitivity towards oxygen, resulting in con-

version back to chlorin and ultimately to porphyrin (Figure 17) [24].

Page 20: Studies toward synthesis of mono-glycosylated ...1049118/FULLTEXT01.pdf · Studies toward synthesis of mono-glycosylated dipyrromethanes and analogues of the anti-cancer natural product

20

Hydroxylation of substituted porphyrins was achieved for the first time in

1930 by Hans Fischer, with the expected product being a chlorin-epoxide, in

which the double bond in pyrrole had undergone epoxidation [25]. Later on,

other strategies of oxidation reactions using symmetrical β-substituted por-

phyrins were performed by other researchers, and it was determined that the

structure of the major product was a keto-chlorin that had arisen from hydro-

gen peroxide/sulfuric acid oxidation, and formed by rearrangement of a diol

or epoxide [26]. After that, more selective reactions were investigated. Chang

et al. reported that free base octaethylporphyrin converted into tetrahy-

droxybacteriochlorin by a selective reaction that included OsO4 in CH2Cl2 and

zinc oxochlorin, produced the isomeric tetrahydroxyisobacteriochlorin as a

major product [27].

Later on, more reactions were performed using OsO4-mediated hydroxyla-

tion as a regioselective reaction. Pandy et al. studied the effect of electron-

withdrawing groups on the OsO4 mediated hydroxylation and the rearrange-

ment of pinacol-pinacolone, and the two pairs of vicinal hydroxy groups were

produced, and can exist in a syn or anti relationship (Figure 18) [28].

Figure 18. Rearrangement of pinacol-pinacolone.

The migration efficiency of electron-withdrawing groups in the pinacol-pi-

nacolone rearrangement can be controlled by the substitution pattern of elec-

tron-withdrawing groups at the peripheral positions of the macrocycles [28].

Page 21: Studies toward synthesis of mono-glycosylated ...1049118/FULLTEXT01.pdf · Studies toward synthesis of mono-glycosylated dipyrromethanes and analogues of the anti-cancer natural product

21

One of the most effective methods for the preparation bacteriochlorins is the

hydroxylation of porphyrin since it provides high selectivity and good yields.

In the hydroxylation method, free base porphyrin controls the selective for-

mation of bacteriochlorin more efficiently as compared to metalated porphy-

rins [27]. Another advantage of hydroxylation reactions of porphyrins is that

bacteriochlorins showed higher stability compared to those that were prepared

by hydrogenation reactions. Still, some disadvantages of hydroxylation reac-

tions methods exist. Firstly, no other β-alkylated porphyrin can be converted

to dioxobacteriochlorins. Secondly, the starting material should display high

symmetry to minimize the number of isomers products, (Figure 19) shows a

number of products produced from non-symmetry starting material. Also,

other by-products can be formed such as chlorins and isobacteriochlorins

Figure 19. The number of products from hydroxylation non-symmetrical porphy-rins.

3.2 Other methods for producing porphyrin and chlorin deriva-

tives.

Until now, many reactions have been discovered for addition of functional

groups to porphyrins and chlorins to increase their scope of use such as PDT,

solar cells, opto-electronics and other applications. One of these methods in-

clude a double Diels-Alder reaction involving di-vinylporphyrins [29], 1,3 di-

polar addition and others, but all of these methods include isomers and some

result in unstable products.

Page 22: Studies toward synthesis of mono-glycosylated ...1049118/FULLTEXT01.pdf · Studies toward synthesis of mono-glycosylated dipyrromethanes and analogues of the anti-cancer natural product

22

3.3 Glycosylated porphyrins, chlorins and bacteriochlorins.

In this section, methods used to prepare meso-substituted and β-substituted

porphyrins, chlorins, and bacteriochlorins will be described. In 2010, Drain

and co-workers reported the facile synthesis and analysis of the photophysical

properties, and in-vitro studies of tetrathioglycosylated porphyrinoids: chlorin

CGLc4, bacteriochlorin BGLc4, and isobacteriochlorin IGLc4, by adjusting the

photophysical properties relative to TPPF20 [30] (Figure 20).

Figure 20. Synthesis of CGlc4, IGlc4 and BGlc4.

Page 23: Studies toward synthesis of mono-glycosylated ...1049118/FULLTEXT01.pdf · Studies toward synthesis of mono-glycosylated dipyrromethanes and analogues of the anti-cancer natural product

23

In two- or three-steps procedures, they prepared CGLc4, BGLc4, and IGLc4

as a suitable platform for developed biochemical tag, diagnostics and photo-

dynamic therapeutic agents related to the photophysical properties of TPPF20

and glycosylated conjugates PGLcAc4 and PGLc4 [31] (Figure 21).

Figure 21. Synthesis of PGlcAc4 and PGlc4 from TPPF20.

3.4 Synthesis of tolyporphin A derivatives.

In 1999 Kishi and his group synthesized O,O-diacetatetolyporphin A by using

iminoester cyclization with extension of the Eschenmoser Sulfide contraction [32]. The spectroscopic and chromatographic analysis showed that the synthetic

O,O-diacetatetolyporphin A was identical to the natural tolyporphin A [32], un-

ambiguously establishing the stereochemistry of tolyporphin A, the figure be-

low shows the O, O-diacetatetolyporphin A building blocks.

Figure 22. Tolyporphin A O,O-diacetate with building blocks.

Page 24: Studies toward synthesis of mono-glycosylated ...1049118/FULLTEXT01.pdf · Studies toward synthesis of mono-glycosylated dipyrromethanes and analogues of the anti-cancer natural product

24

The stepwise synthesis of tolyporphin A is too complex for practical use

(more than 20 steps) and with low yield (< 5 mg) to serve as a general method

for the preparation of bacteriochlorin. Therefore, for fundamental studies or

other applications in materials chemistry, in naturally occurring bacteriochlo-

rin, de novo synthesis is the only way for tolyporphin synthesis.

3.5 Glycosylated pyrroles.

Of the two positions in the pyrrole ring that can react with electrophiles, posi-

tion, 2 is more reactive than position 3. In 2002, Armitt et al. prepared C-

glycosides by using O-glycosylimidates and pyrrole in presence of BF3·Et2O.

The reaction produced 2-galacto, manno- and lactopyrroles as well as the ben-

zyl protected 2-glycosyl pyrrole which were acquired in good yields.

Figure 23. Preparation of pyrrole-C-glycosylated using the glycosyl donors under

BF3.Et2O.

3.6 Glycosylation of pyrrole at position 3.

The group of Borbas tried to use the same procedure but with N-TIPS-pyrrole

to block position 2 and steer the reaction to position 3 [33]. In this work N-

TIPS-pyrrole with a trichloroacetimidate donor was used under the same con-

ditions to produce 3-glycosylated pyrroles as building blocks for glycosylated

tetrapyrrole macrocycles. The reaction of the O-benzyl protected trichloroa-

cetimidate was, however, poorly selective.

Page 25: Studies toward synthesis of mono-glycosylated ...1049118/FULLTEXT01.pdf · Studies toward synthesis of mono-glycosylated dipyrromethanes and analogues of the anti-cancer natural product

25

Figure 24. Reaction of the glycosyl donor with TIPS-pyrrole.

The same group also attempted a potentially more selective pathway to

prepare 3-glycosylated pyrroles, (Figure 25 and 26) [34].

Figure 25. Preparation of glycosyl donor with new substrate.

This glycosyl donor was reacted with N-TIPS pyrrole under TMSOTf pro-

motion in dry DCM at -20 °C. The reaction was quenched by addition of

TBAF·3H2O to get 3-glycosylpyrrole (Figure26).

Figure 26. Preparation of 3-glycosylated pyrrole [33].

Page 26: Studies toward synthesis of mono-glycosylated ...1049118/FULLTEXT01.pdf · Studies toward synthesis of mono-glycosylated dipyrromethanes and analogues of the anti-cancer natural product

26

3.7 Conversion of glycosylated pyrrole to dipyrromethane.

Dipyrromethanes can be synthesized from aldehydes and pyrrole which are

reacted in the presence of acid [35]. 3-Glycosylated pyrroles prepared by the

described method, synthesis of mono-and diglycosylated dipyrromethane can

be used by different synthetic routes (Figure 27).

Figure 27. Pathways of preparation of glycosylated dipyrromethanes [33].

3.8 Diglycosylated dipyrromethanes.

Earlier studies have demonstrated the possibility of preparing diglycosylated

dipyrromethanes from 2-glycosyl-pyrrole which had reacted with benzalde-

hyde in the presence of TFA [35]. The same protocol gave traces for 3-glyco-

sylated pyrroles. The reasons will be discused later, (Figure 28) shows the

reactions and the reaction conditions.

Figure 28. Preparation of diglycosylated dipyrromethane [33].

Page 27: Studies toward synthesis of mono-glycosylated ...1049118/FULLTEXT01.pdf · Studies toward synthesis of mono-glycosylated dipyrromethanes and analogues of the anti-cancer natural product

27

3.9 Preparing porphyrin.

Lindsey et al. developed a rational route to trans-AB-porphyrins [36]. They

chose Western half dipyrromethane (5-phenyl dipyrromethane) to interact

with mono-glycosylated dipyrromethane. The Western half can be prepared

by reacting pyrrole with benzaldehyde in presence of InCl3 as a catalyst [37].

Following this step, dipyrromethane was diformylated with POCl3 and DMF

(Vilsmeier formylation) [38], then reacted with propylamine in THF for 1 h to

give 1,9-bis(imino)-5-phenyl dipyrromethane.

Figure 29. Preparation of Eastern half of dipyrromethane.

By refluxing the mixture of Western half and Eastern half for 15 h in pres-

ence of Zn(OAc)2, followed by purification by column chromatography gave

2 mg of the mixture of products (Figure 30).

Figure 30. Preparation of monoglycosylated porphyrin.

3.10 Mono glycosylation of dipyrromethane in regioselective reac-

tion

Other productive pathways of more selective reactions were also worked out.

3-Glycosyl pyrrole was reacted with pyrrole to get monoglycosyl dipyrro-

methane. 2 Eq of Eschenmoser salt in DCM was reacted with the substrate to

produce 3-glycosylated pyrrole (Figure 31), the reaction was highly regiose-

lective and reproducible [39].

Page 28: Studies toward synthesis of mono-glycosylated ...1049118/FULLTEXT01.pdf · Studies toward synthesis of mono-glycosylated dipyrromethanes and analogues of the anti-cancer natural product

28

Figure 31. Reaction of glycosylated pyrrole with Eschenmoser salt.

After that, the product was reacted with neat distilled pyrrole in the micro-

wave for 30 min at 150 °C and the product was purified by column chroma-

tography to get monoglycosyl dipyrromethane (Figure 32).

Figure 32. Glycosylated dipyrromethane formation.

The same route was followed with the other half of 5-phenyldipyrro-

methane to get monoglycosylated porphyrin without isomers (Figure 46).

Page 29: Studies toward synthesis of mono-glycosylated ...1049118/FULLTEXT01.pdf · Studies toward synthesis of mono-glycosylated dipyrromethanes and analogues of the anti-cancer natural product

29

4 Results and discussion.

From the previous discussed results it can be concluded that the Armitt et al.

reaction was useful for 2-glycosylated pyrroles, but when the same procedure

was applied to make N-TIPS-pyrrole to produce 3-glycosylated products, it

was irreproducible.

Because the C-glycosylation of pyrrole at 3-position is challenging, strate-

gies using a new leaving group was chosen. N-phenyl-triflouroacetimidate

was the optimal solution to achieve a selective reaction [40]. N-2,2,2-triflouro-

acetimidoyl chloride was prepared from standard procedure [34]. Triflouroace-

timidate glycosyl donor was produced by using either of these bases, (DIPEA [41], NaH [42], CsCO3

[43], DBU [44], or K2CO3 [45]), and was obtained in 97%

yield using K2CO3. The compound is temperature sensitive and decomposes

at room temperature after two weeks, but is stable for several months at 4 °C.

Figure 33. Preparation of glycosyl donor.

4.1 Selectivity of glycosylation of N-TIPS-pyrrole

When N-phenyl-triflouroacetimidate glycosyl donor was applied high selec-

tivity for the β-anomer was observed, and 40% yield after two reaction steps

was achieved (Figure 33).

4.2 Glycosylation of N-TIPS-pyrrole

Based on previous results, PTFAI was chosen as donor for the reaction with

N-TIPS-pyrrole by following a literature procedure [46]. A glycosidic coupling

was used between N-pentenoyl hydroxamic acid and a PTFAI donor after

TMSOTf activation according to published procedures [47]. Optimization of

condition resulted in good yield.

Purification of 3-glycosylated TIPS pyrrole was problematic, but after the

temperature changing had been studied, the optimum reaction temperature

was -20 °C with 20 min waiting time.

Page 30: Studies toward synthesis of mono-glycosylated ...1049118/FULLTEXT01.pdf · Studies toward synthesis of mono-glycosylated dipyrromethanes and analogues of the anti-cancer natural product

30

Temperature, time, and quenching were optimized for best yield: -20 °C at

35 min with quenching with 5 eq of TBAF proved optimal condition and pro-

duced 41% yield.

4.3 Mono-glycosylated dipyrromethanes.

Based on previous results with dipyrromethanes, two different strategies were

studied. In the first strategy, commercially available 2-formylpyrrole was used

as starting material to react with benzylpyrrole which was prepared from ben-

zylmorpholine and POCl3 forming Vilsmeier reagent [48]. (Figure 34) shows

the results of previous work [33].

Figure 34. Previous reaction steps to produce mono glycosylated porphyrin.

This strategy failed as judged by the lack of product dipyrromethane. Also,

the reduction of the carbonyl function did not give any dipyrromethane as

shown in (Figure 35).

Page 31: Studies toward synthesis of mono-glycosylated ...1049118/FULLTEXT01.pdf · Studies toward synthesis of mono-glycosylated dipyrromethanes and analogues of the anti-cancer natural product

31

Figure 35. Failed strategies to produce glycosylated dipyrromethanes.

In the other strategy, shown in Figure 35, the Vilsmeier reagent formylation

reaction was applied directly to glycosylated pyrrole. The yield after overnight

reaction was satisfactory but the selectivity was not. The reaction occurred on

both sides of the glycosylated pyrrole (Figure 36 and 37) and it was difficult

to isolate the desired product.

Figure 36. Vilsmeier reaction with glycosylated pyrrole.

Figure 37. Other products from Vilsmeier reaction

.

Page 32: Studies toward synthesis of mono-glycosylated ...1049118/FULLTEXT01.pdf · Studies toward synthesis of mono-glycosylated dipyrromethanes and analogues of the anti-cancer natural product

32

4.4 The new results.

At this point, new strategies producing more efficient selectivity, and better

yields were tested. Reactions that described attachment of an electrophilic

group at position 2 in 3-glycosylated pyrrole was tried. Other procedures such

as benzoyl chloride in presence of MesMgBr was also tested.

Figure 38. Bromination of 3- glycosylated pyrrole.

Reacting the substrate with NBS in THF at -78 °C was also tested,

Figure 39. Bromination of 3- glycosylated pyrrole with other condition.

or with NIS in THF at -94 °C.

Figure 40. Iodination of glycosylated pyrrole.

After that p-bromobenzaldehyde was used in the presence of piperidine and

DCM, repeating the reaction with toluene as a solvent.

Figure 41. Preparation of diglycosylated dipyrromethane.

Page 33: Studies toward synthesis of mono-glycosylated ...1049118/FULLTEXT01.pdf · Studies toward synthesis of mono-glycosylated dipyrromethanes and analogues of the anti-cancer natural product

33

Also morphilino(phenyl)methanone in presence of POCl3 in THF was reacted

with the substrate.

Figure 42. Preparation of 2-bezoyl-4-glycosylated pyrrole.

All of the described attempts were unsuccessful.

Table 1. Unsuccessful reactions.

Reagent Time/

min

Temp Solvent Yield %

MesMgBr/benzoylchlo-

ride

30 -78 °C THF aNR

NBS 30 -78 °C THF NR

NBS 30 -94 °C THF Mixture of

products

NIS 30 -94 °C THF NR

p-benzoylbromide 30 DCM or

toluene

NR

a = No Reaction.

4.5 Eschenmoser salt as a reagent.

Finally, in a very facile reaction, including 2 eq of Eschenmoser salt in THF

at room temperature for 20 min resulted in 95 % yield.

The reaction was easy to perform, not sensitive to moisture and reproduci-

ble. Figure 43 shows the reaction conditions. The reaction was highly selective

and no by-product was observed.

Figure 43. Preparation of glycosylpyrrole donor in presence of Eschonmoser salt.

40 mg (0.094 mmol) of 3-glycosylated pyrrole was dissolved in DCM at rt,

Eschonmoser salt (2 eq) was added in one portion, the mixture was stirred for

20 min, then the reaction was quenched with saturated NaHCO3, the aqueous

Page 34: Studies toward synthesis of mono-glycosylated ...1049118/FULLTEXT01.pdf · Studies toward synthesis of mono-glycosylated dipyrromethanes and analogues of the anti-cancer natural product

34

layer was extracted twice. The organic layer was dried by dry Na2SO4, the

solvent was evaporated, no more purification needed with 95% yield [39].

4.6 Mono-glycosylated dipyrromethanes synthesis.

The compound with a dimethyl ethylamino group was reacted with 10 %

ZnCl2 and pyrrole neat, under room temperature. This reaction was, however,

unsuccessful. After this, the substrate was reacted with InCl3 and pyrrole neat,

also without success. The reaction was repeated with Zn(OAc)2 and 5 eq of

pyrrole in THF, EtOH and toluene as a solvents, again without product for-

mation.

Finally, microwave assisted heating of the substrate and pyrrole at 150 °C

for 30 min resulted in optimal results [39].

Figure 44. Formation of glycosylated dipyrromethane.

15 mg (0.031 mmol) of the product (Figure 43) was placed in microwave vial

and dissolved in 2.5 mL pyrrole, the vial was placed in a microwave for 30

min at 150 °C. Then, the pyrrole was evaporated and the residue was purified

by column chromatography with 44 % yield [39].

Table 2. Optimization reaction of glycosylated dipyrromethane.

Time/ min Temp Solvent Yield

30 80 °C Pyrrole Reaction not completed

30 100 °C Pyrrole Reaction not completed

30 120 °C Pyrrole Reaction not completed

15 150 °C Pyrrole Reaction not completed

30 150 °C Pyrrole 44 %

Page 35: Studies toward synthesis of mono-glycosylated ...1049118/FULLTEXT01.pdf · Studies toward synthesis of mono-glycosylated dipyrromethanes and analogues of the anti-cancer natural product

35

1H NMR (400 MHz, Chloroform-d) δ 8.33 (s, 1H), 8.17 (s, 1H), 6.71 (s, 1H),

6.18 (t, J=2.6 Hz, 1H), 6.04 (d, J =2.9 Hz, 2H), 5.93-5.82 (m, 1H), 5.31 (td,

J=9.5 Hz, 1H), 5.10 (dt, J=25.2, 9.7 Hz, 2H), 4.45-4.32 (m, 1H), 4.28 (dd,

J=12.4, 4.8 Hz, 1H),4.16-4.05 (m, 2H), 3.98 (d, J=2.6 Hz, 2H), 3.85-3.73 (m,

1H), 2.12-1.98 (m, 11H), 1.89 (t, J=1.3 Hz, 3H).

4.7 Second part of dipyrromethane preparation.

Commercially available 5-phenyl dipyrromethane was used to prepare di-for-

mulated dipyrromethane in presence of POCl3 and DMF at 0 °C by standard

procedure [36]. The product was subsequently reacted with propylamine in

THF at room temperature to give 1,9-bis(imino)-5-phenyl-dipyrromethane [38],

(Figure 45).

Figure 45. Formylation of dipyrromethane.

4.8 Preparation of porphyrin.

The last step of this multi-steps synthesis was to react the two of dipyrro-

methanes parts to yield the mono-glycosylated porphyrin. This was done by

refluxing the reactants with Zn(OAc)2 in presence of toluene, followed by col-

umn chromatography to get a redish fluorescent solid compound as shown

below.

Figure 46. Reaction of the two parts of dipyrromethane.

A 5.5 mg (0.015 mmol) of 5-phenyl-1,9-bis(N-propylimino) dipyrromethane

was dissolved in anhydrous toluene in dry flask, 7.2 mg (0.015 mmol) was

Page 36: Studies toward synthesis of mono-glycosylated ...1049118/FULLTEXT01.pdf · Studies toward synthesis of mono-glycosylated dipyrromethanes and analogues of the anti-cancer natural product

36

dissolved in 1 mL dry toluene, then the solution was added to the first reactant,

27.3 mg (0.15 mmol) of Zn(OAc)2 was added. The reaction mixture was re-

fluxed overnight, the solvent was evaporated and the residue was purified by

column chromatography with 3 mg pink product

1H NMR (400 MHz, Chloroform-d) δ 10.28 (s, 1H), 10.23 (s, 1H), 9.54 (s,

1H), 9.46 (d, 1H), 9.41 (t, J=5.0 Hz, 1H), 9.12 (d, J=4.5 Hz, 1H), 8.24 (dd,

J=19.7, 6.8 Hz, 1H), 7.79 (dq, J=8.7, 5.4, 4.6 Hz, 2H), 6.35 (d, J=9.8 Hz, 1H),

6.06 (t, J=9.6 Hz, 1H), 5.88 (t, J=9.4 Hz, 1H), 5.70 (t, J=9.8 Hz, 1H), 5.30 (d,

J=1.3 Hz, 1H), 4.60 (dd, J=12.6, 5.0 Hz, 1H), 4.55-4.43 (m, 1H), 2.21 (dd,

J=7.6, 1.3 Hz, 4H), 2.09 (s, 2H), 1.26 (d, J=2.2 Hz, 9H).

Page 37: Studies toward synthesis of mono-glycosylated ...1049118/FULLTEXT01.pdf · Studies toward synthesis of mono-glycosylated dipyrromethanes and analogues of the anti-cancer natural product

37

5 Conclusion

In this work, new pathways of synthesis have been applied to produce glyco-

sylated dipyrromethanes and mono-glycosylated porphyrin, and the synthesis

strategies have been compared with similar work.

Reaction conditions resulting in selective and high-yield production of

mono glycosylated dipyrromethane have been established.

From the results discussed here, I have some suggestions for future work.

Firstly, it would be a good idea if also other mono-saccharides, such as man-

nose, galactose, or di-saccharides, such as sucrose could be applied in the re-

action synthesis and the differences between sugar substrates could be as-

sessed. Secondly, the physical properties of mono-glycosylated porphyrin

could be studied compared to tolyporphin natural products.

Page 38: Studies toward synthesis of mono-glycosylated ...1049118/FULLTEXT01.pdf · Studies toward synthesis of mono-glycosylated dipyrromethanes and analogues of the anti-cancer natural product

38

Appendix

Page 39: Studies toward synthesis of mono-glycosylated ...1049118/FULLTEXT01.pdf · Studies toward synthesis of mono-glycosylated dipyrromethanes and analogues of the anti-cancer natural product

39

Page 40: Studies toward synthesis of mono-glycosylated ...1049118/FULLTEXT01.pdf · Studies toward synthesis of mono-glycosylated dipyrromethanes and analogues of the anti-cancer natural product

40

Page 41: Studies toward synthesis of mono-glycosylated ...1049118/FULLTEXT01.pdf · Studies toward synthesis of mono-glycosylated dipyrromethanes and analogues of the anti-cancer natural product

41

References:

[1] a) E. D. Sternberg, D. Dolphin, C. Brückner, Tetrahedron

1998, 54, 4151–4202; b) T. D. Mody, J. Porphyr. Phthalocya.

2000, 4, 362–367; c) I. J. MacDonald, T. J. Dougherty, J.

Porphyr. Phthalocya. 2001, 5, 105–129.

[2] a) S. Gowda, G. L. Mathur, Q., S. Surthi, Q. Zhao, J. S.

Lindsey, K. Mobley, D. F. Bocian, V. Misra, Technical

Digest-IEEE Meeting on Electron Devices. 2003, 537–540; b)

Z. Liu, A. A. Yasseri, J. S. Lindsey, D. F. Bocian, Science

2003, 1543–1545.

[3] W. M. Campbell, A. K. Burrell, D. L. Officer, K. W. Jolley,

Coordin. Chem. Rev 2004, 1363–1379.

[4] a) R. W. Wagner, J. S. Lindsey, J. Seth, V. Palaniappan, D. F.

Bocian, J. Am. Chem. Soc. 1996, 118, 3996–3997; b)

Benniston, A. Chem. Soc. Rev. 2004, 33, 573–578.

[5] P. Rothemund, J. Am. Chem. Soc. 1936, 58, 625–627.

[6] a) P. Rothemund., J. Am. Chem. Soc. 1935, 57, 2010–2011; b)

A. D. Adler, F. R. Longo, J. D. Finarelli, J. Goldmacher, J.

Assour, L. Korsakoff, J. Org. Chem. 1967, 32, 476–476.

[7] J. S. Lindsey, Acc. Chem. Res. 2010, 43, 300-311.

[8] H. Scheer, In Chlorophylls; Scheer, H. Ed.; CRC Press: Boca

Raton, FL, USA. 1991, 3–30.

[9] J. T. L. Chiu, P. C.; Switala, J.; Gennis, R. B.; Timkovich, R.,

J. Am. Chem. Soc. 1989, 111, 7046–7050.

[10] F.-P. Montforts, B. Gerlach, F. Höper, Chem. Rev. 1994, 94,

327–347.

[11] a) F.-P. G.-B. Montforts, M. Prog., Heterocycl Chem. 1998,

10, 1–24; b) C. J. Dutton, C. J. R. Fookes, A. R. Battersby,

Chem. Commun. 1983, 1237–1238; c) A. R. Battersby, C. J. R.

Fookes, R. J. Snow, J. Chem. Soc. Perkin Trans. 1 1984,

2725–2732; d) A. R. Battersby, C. J. Dutton, C. J. R. Fookes,

J. Chem. Soc. Perkin Trans. 1. 1988, 1569–1576.

[12] T. J. Michalski, J. E. Hunt, M. K. Bowman, U. Smith, K.

Bardeen, H. Gest, J. R. Norris, J. Katz, J. Proc. Natl. Acad.

Sci. USA. 1987, 84, 2570–2574.

[13] a) M. Gottesman, I. Pastan, Annu. Rev. Biochem. 1993, 62,

385-427; b) M. Sanford, S. a. M. Schindlert., Proc. Natl. Acad.

Sci. USA. 1994, 91, 3497.

Page 42: Studies toward synthesis of mono-glycosylated ...1049118/FULLTEXT01.pdf · Studies toward synthesis of mono-glycosylated dipyrromethanes and analogues of the anti-cancer natural product

42

[14] a) M. R. Prinsep, F. R. Caplan, R. E. Moore, G. M. L.

Patterson, C. D. Smith, J. Am. Chem. Soc. 1992, 114, 385-387;

b) M. R. Prinsep, G. M. L. Patterson, L. K. Larsen, C. D.

Smith, Tetrahedron. 1995, 51, 10523-10530; c) M. R. Prinsep,

G. M. L. Patterson, L. K. Larsen, C. D. Smith, J. Nat. Prod.

1998, 61, 1133-1136.

[15] a) T. G. Minehan, Y. Kishi, Angew. Chem. Int. Ed. 1999, 923;

b) W. Wang, Y. Kishi, Org. Lett. 1999, 1129.

[16] a) P. A. Jacobi, H. Liu, J. Org. Chem. 1999, 64, 1778; b) P. A.

Jacobi, C. Tassa, Org. Lett. 2003, 5, 4879; c) P. A. Jacobi, Y.

Li, Org. Lett. 2003, 5, 701; dD. Fan, M. Taniguchi, Z. Yao, S.

Dhanalekshmi, J. S. Lindsey, Tetrahedron. 2005, 61, 10291.

[17] B. Yu, J. Sun, Chem. Commun. 2010, 46, 4668-4678.

[18] T. Tsuchimoto, Chem. Eur. J. 2011, 17, 4064-4075.

[19] D. P. O'Malley, K. Li, M. Maue, A. L. Zografos, P. S. Baran,

J. Am. Chem. Soc. 2007, 129, 4762-4775.

[20] C. Teixeira, F. Barbault, J. Rebehmed, K. Liu, L. Xie, H. Lu,

S. Jiang, B. Fan, F. Maurel, Bioorg.Med. Chem. 2008, 16,

3039.

[21] D. S. Mukherjee, S. K.; Chowdhury, U. S.; Taneja, S. C.,

Tetrahedron Lett. 2007, 48, 663-667.

[22] G. D. Dorough, J. R. Miller, J. Am. Chem. Soc. 1952, 74, 6106

[23] H. W. J. Whitlock, R. Hanauer, M. Y. Oester, B. K. Bower, J.

Am. Chem. Soc. 1969, 91, 7485.

[24] J. Oelze, Methods Microbiol. 1985, 18, 257.

[25] H. Fischer, H. D. C. d. P. Orth, Akademische

Verlagsgesselschaft: Leipzig, 1937, 2, 269.

[26] H. H. Inhoffen, W. Nolte, Liebigs Ann. Chem. 1969, 725, 167.

[27] C. K. Chang, C. Sotiriou, W. Wu, J. Chem. Soc. Chem.

Commun. 1986, 1213

[28] a) G. Zheng, T. J. Dougherty, R. K. Pandey, J. Org. Chem.

1999, 64, 3751; b) Y. Chen, C. J. Medforth, K. M. Smith, J.

Alderfer, T. J. Dougherty, R. K. Pandey, J. Org. Chem. 2001,

66, 3930.

[29] a) P. Yon-Hin, T. P. Wijesekera, D. Dolphin, Tetrahedron Lett

1991, 32, 2875; b) M. G. H. Vincente, M. T. Cancilla, C. B.

Lebrilla, K. M. Smith, Chem.Commun. 1998, 2355.

Page 43: Studies toward synthesis of mono-glycosylated ...1049118/FULLTEXT01.pdf · Studies toward synthesis of mono-glycosylated dipyrromethanes and analogues of the anti-cancer natural product

43

[30] S. A. singh, A.; Thompson, S.; Tome, J. o. P. C.; Zhu, X.;

Samaroo, D.; Vinodu, M.;Gao, R.; Drain, C. M, Bioconjugate

Chem. 2010, 21, 2136

[31] a) X. Chen, L. Hui, D. A. Foster, C. M. Drain, Biochemistry

2004, 43, 10918; b) S. Hirohara, M. Obata, H. Alitomo, K.

Sharyo, T. Ando, M. Tanihara, S. Yano, J. photochem.

photobiol., B 2009, 97, 22.

[32] W. Wang, Y. Kishi, Org. Lett. 1999, 1, 1129.

[33] C. Sollert, Personal communication (master thesis), Stokholm

University. 2012.

[34] K. Tamura, H. Mizukami, K. Maeda, H. Watanabe, K.

Uneyama, J. org. chem. 1993, 58, 32.

[35] C. H. Lee, J. S. Lindsey, Tetrahedron. 1994, 50, 11427.

[36] M. Taniguchi, A. Balakumar, D. Fan, B. E. McDowell, J. S.

Lindsey, J. porphyr. phthalocya. 2005, 9, 554.

[37] J. K. Laha, S. Dhanalekshmi, M. Taniguchi, A. Ambroise, J. S.

Lindsey, Org. Process. Res. Dev. 2003, 7, 799.

[38] K. E. Borbas, P. Mroz, M. R. Hamblin, J. S. Lindsey, Bioconj.

Chem. 2006, 17, 638.

[39] R. B. Xiong, K. E. Borbas, Syn. Lett. 2014, 25, A-E.

[40] B. Yu, J. Sun, Chem. Commun. 2010, 46, 4668.

[41] M. Adinolfi, G. Barone, A. Iadonisi, S. M., Tetrahedron lett

2002, 43, 5573.

[42] D. Comegna, E. Bedini, A. D. Nola, A. Iadonisi, M. Parrilli,

Carbohydr. Res. 2007, 342, 1021

[43] T. Doi, A. Kinbara, H. Inoue, T. Takahashi, Chemistry – An

Asian Journal. 2007, 2, 188.

[44] H. Tanaka, Y. Iwata, D. Takahashi, M. Adachi, T. Takahashi,

J. Am. chem. soc. 2005, 127, 1630.

[45] B. Yu, H. Tao, J. Org. Chem. 2002, 67, 9099.

[46] B. L. Bray, P. H. Mathies, R. Naef, D. R. Solas, T. T. Tidwell,

D. R. Artis, J. M. Muchowski, J. Org. Chem. 1990, 55, 6317

[47] J. E. Hudak, H. H. Yu, C. R. Bertozzi, J. Am. Chem. Soc.

2011, 133, 16127

[48] D. M. Wallace, S. H. Leung, M. O. Senge, K. M. Smith, J.

Org. Chem. 1993, 58, 7245.

Page 44: Studies toward synthesis of mono-glycosylated ...1049118/FULLTEXT01.pdf · Studies toward synthesis of mono-glycosylated dipyrromethanes and analogues of the anti-cancer natural product

44